Method of treating activated B cell nuclear factor kappa light chain enhancer (NF-κB) dysregulation using eggshell membrane compositions in a host in need thereof

摘要

The present invention addresses the use of eggshell membrane compositions and NF-κB dysregulation to activate levels of activated B cell nuclear factor kappa light chain enhancer (“NF-κB”) in the gastrointestinal tract of the host in need thereof. It relates to a method for treating related conditions. The present invention provides a method of activating NF-κB in the gastrointestinal tract of a host in need thereof. The method comprises administering to the host an effective amount of a composition consisting essentially of eggshell membranes and / or eggshell membrane isolates and / or eggshell membrane hydrolysates to activate NF-κB. Including.